BriaCell Therapeutics Corp.
BCTX
$2.02
-$0.05-2.42%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 148.53% | -13.44% | 571.88% | -7.87% | -85.02% |
| Total Receivables | 8.19% | -11.45% | 229.55% | 4,744.74% | -49.50% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -55.11% | -16.25% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 106.42% | -12.85% | 124.94% | -33.93% | -52.90% |
|
|
|||||
| Total Current Assets | 106.42% | -12.85% | 124.94% | -33.93% | -52.90% |
| Net Property, Plant & Equipment | -6.66% | -6.24% | -5.90% | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -2.03% | -1.94% | -1.90% | -1.87% | -1.83% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | -- | -- |
| Total Assets | 81.57% | -10.09% | 77.35% | -5.34% | -49.28% |
|
|
|||||
| Total Accounts Payable | -34.46% | 18.17% | -40.95% | 11.65% | 73.04% |
| Total Accrued Expenses | 361.95% | -69.84% | 159.88% | -13.42% | 57.54% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -17.21% | 4.86% | -33.14% | 10.41% | 72.20% |
|
|
|||||
| Total Current Liabilities | -17.21% | 4.86% | -33.14% | 10.41% | 72.20% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -19.41% | -47.11% | 56.27% | -80.70% | -65.84% |
| Total Liabilities | -17.54% | -8.43% | -21.69% | -31.19% | -39.48% |
|
|
|||||
| Common Stock & APIC | 10.03% | 4.16% | 13.68% | 3.70% | 0.00% |
| Retained Earnings | -6.28% | -6.89% | -6.79% | -1.44% | 2.00% |
| Treasury Stock & Other | 40.59% | 18.43% | 21.60% | 25.62% | 4.74% |
| Total Common Equity | 244.59% | -10.88% | 269.69% | 60.06% | 26.11% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 244.59% | -10.88% | 269.69% | 60.06% | 26.11% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -26.09% | -14.08% | -8.96% | -12.92% | -9.62% |
| Total Equity | 270.05% | -13.09% | 238.29% | 56.92% | 25.06% |
|
|
|||||